• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSP7在肺损伤期间通过靶向纤溶途径保护肺泡上皮细胞。

CSP7 Protects Alveolar Epithelial Cells by Targeting -Fibrinolytic Pathways During Lung Injuries.

作者信息

Puthusseri Bijesh, Bhagavath Ashoka Kumar, Korir Daniel, Shetty Rashmi, Johnson Gretchen A, Stankowska Dorota L, Konduru Nagarjun V, Tang Hua, Bolla Sudhir, Criner Gerald J, Marchetti Nathaniel, Das Durgesh Nandini, Shetty Sreerama

机构信息

The University of Texas Health Science Center at Tyler, Tyler, Texas, United States.

University of North Texas Health Science Center, Fort Worth, Texas, United States.

出版信息

Am J Respir Cell Mol Biol. 2024 Sep 13;72(1):97-108. doi: 10.1165/rcmb.2023-0453OC.

DOI:10.1165/rcmb.2023-0453OC
PMID:39269467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707667/
Abstract

Impaired alveolar epithelial regeneration in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) is attributed to telomere dysfunction in type II alveolar epithelial cells (ACs). Genetic susceptibility, aging, and toxicant exposures, including tobacco smoke (TS), contribute to telomere dysfunction in ACs. Here we investigated whether improvement of telomere function plays a role in CSP7-mediated protection of ACs against ongoing senescence and apoptosis during bleomycin (BLM)-induced pulmonary fibrosis (PF) as well as alveolar injury caused by chronic TS exposure. We found a significant telomere shortening in ACs isolated from IPF and COPD lungs in line with other studies. These cells showed increased in addition to its post-translational modification with induction of activated and , suggesting a -mediated loss of AC renewal. Further, we found increased expression of , a -inducible E3 ubiquitin ligase known to down-regulate telomere repeats binding factor 2 (). Consistent with the loss of and upregulation of , telomerase reverse transcriptase () was downregulated in ACs. ACs from fibrotic lungs of mice either repeatedly instilled with BLM or isolated from chronic TS exposure-induced lung injury model showed reduced telomere length along with induction of , , and as well as loss of and , which were reversed in wild-type mice after treatment with CSP7. Interestingly, mice, or those lacking microRNA-34a expression in ACs, resisted telomere dysfunction, while mice failed to respond to CSP7 treatment, suggesting feed-forward induction and pathway contributes to telomere dysfunction.

摘要

特发性肺纤维化(IPF)和慢性阻塞性肺疾病(COPD)患者的肺泡上皮再生受损归因于II型肺泡上皮细胞(ACs)中的端粒功能障碍。遗传易感性、衰老以及包括烟草烟雾(TS)在内的有毒物质暴露均会导致ACs中的端粒功能障碍。在此,我们研究了端粒功能的改善是否在CSP7介导的对博来霉素(BLM)诱导的肺纤维化(PF)过程中ACs持续衰老和凋亡以及慢性TS暴露引起的肺泡损伤的保护作用中发挥作用。我们发现,与其他研究一致,从IPF和COPD肺中分离出的ACs存在明显的端粒缩短。这些细胞除了其翻译后修饰增加并诱导活化的 和 外,还显示出 增加,提示 介导的AC更新丧失。此外,我们发现 表达增加, 是一种已知可下调端粒重复结合因子2( )的 诱导型E3泛素连接酶。与 的丧失和 的上调一致,端粒酶逆转录酶( )在ACs中下调。反复注入BLM的小鼠纤维化肺中的ACs或从慢性TS暴露诱导的肺损伤模型中分离出的ACs显示端粒长度缩短,同时诱导 、 、 和 以及丧失 和 ,在用CSP7治疗后野生型小鼠中这些情况得到逆转。有趣的是, 小鼠或ACs中缺乏微小RNA - 34a表达的小鼠抵抗端粒功能障碍,而 小鼠对CSP7治疗无反应,提示 前馈诱导和 途径导致端粒功能障碍。

相似文献

1
CSP7 Protects Alveolar Epithelial Cells by Targeting -Fibrinolytic Pathways During Lung Injuries.CSP7在肺损伤期间通过靶向纤溶途径保护肺泡上皮细胞。
Am J Respir Cell Mol Biol. 2024 Sep 13;72(1):97-108. doi: 10.1165/rcmb.2023-0453OC.
2
Dyskeratosis Congenita and Related Telomere Biology Disorders先天性角化不良及相关端粒生物学障碍
3
LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling.LMO7通过转化生长因子-β信号通路驱动小鼠体内促纤维化成纤维细胞极化和肺纤维化。
Acta Pharmacol Sin. 2025 Feb 25. doi: 10.1038/s41401-025-01488-9.
4
Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis.血液中Y染色体的嵌合缺失与男性特发性肺纤维化易感性相关。
Commun Med (Lond). 2025 Jun 28;5(1):246. doi: 10.1038/s43856-025-00966-9.
5
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
6
NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.特发性肺纤维化和慢性阻塞性肺疾病中的NFATc3与血管活性肠肽
PLoS One. 2017 Jan 26;12(1):e0170606. doi: 10.1371/journal.pone.0170606. eCollection 2017.
7
Comparison of Telomere Structure in Eukaryotes.真核生物中端粒结构的比较。
Arch Razi Inst. 2024 Dec 31;79(6):1365-1374. doi: 10.32592/ARI.2024.79.6.1365. eCollection 2024 Dec.
8
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
9
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
10
A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.基于博来霉素诱导的优化肺纤维化小鼠模型所开发的、利用微型计算机断层扫描(Micro-CT)图像的一种新型肺纤维化量化方法。
Heliyon. 2023 Feb 10;9(3):e13598. doi: 10.1016/j.heliyon.2023.e13598. eCollection 2023 Mar.

引用本文的文献

1
Cav1 Scaffolding Domain Peptide (CSP7): A Novel Target for Idiopathic Pulmonary Fibrosis.Cav1支架结构域肽(CSP7):特发性肺纤维化的新靶点。
Am J Respir Cell Mol Biol. 2024 Sep 18;72(1):14-5. doi: 10.1165/rcmb.2024-0314ED.

本文引用的文献

1
Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury.窖蛋白-1 衍生肽减轻香烟烟雾诱导的气道和肺泡上皮损伤。
Am J Physiol Lung Cell Mol Physiol. 2023 Nov 1;325(5):L689-L708. doi: 10.1152/ajplung.00178.2022. Epub 2023 Aug 29.
2
Divergent Regulation of Alveolar Type 2 Cell and Fibroblast Apoptosis by Plasminogen Activator Inhibitor 1 in Lung Fibrosis.纤溶酶原激活物抑制剂 1 对肺纤维化中肺泡 2 型细胞和成纤维细胞凋亡的不同调节作用。
Am J Pathol. 2021 Jul;191(7):1227-1239. doi: 10.1016/j.ajpath.2021.04.003. Epub 2021 Apr 20.
3
Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.肺泡上皮细胞质量控制对肺纤维化的贡献。
J Clin Invest. 2020 Oct 1;130(10):5088-5099. doi: 10.1172/JCI139519.
4
Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of Lung Cancer: Findings from the Fukuoka Tobacco-Related Lung Disease (FOLD) Registry.端粒相关多态性与特发性肺纤维化和慢性阻塞性肺疾病作为肺癌前驱病变的风险之间的关联:来自福冈烟草相关肺病(FOLD)登记处的研究结果。
Asian Pac J Cancer Prev. 2020 Mar 1;21(3):667-673. doi: 10.31557/APJCP.2020.21.3.667.
5
Telomeres and Telomere Length: A General Overview.端粒与端粒长度:概述
Cancers (Basel). 2020 Feb 28;12(3):558. doi: 10.3390/cancers12030558.
6
Caveolin-1-derived peptide limits development of pulmonary fibrosis.窖蛋白-1 衍生肽可抑制肺纤维化的发展。
Sci Transl Med. 2019 Dec 11;11(522). doi: 10.1126/scitranslmed.aat2848.
7
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF).特发性肺纤维化(IPF)的药物治疗及辅助治疗
J Thorac Dis. 2019 Sep;11(Suppl 14):S1740-S1754. doi: 10.21037/jtd.2019.04.62.
8
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives.药物开发指导治疗慢性阻塞性肺疾病的综述:美国和欧盟的观点。
Clin Pharmacol Ther. 2019 Dec;106(6):1222-1235. doi: 10.1002/cpt.1540. Epub 2019 Jul 23.
9
Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence.端粒酶逆转录酶通过保护肺泡上皮细胞免于衰老来改善肺纤维化。
J Biol Chem. 2019 May 31;294(22):8861-8871. doi: 10.1074/jbc.RA118.006615. Epub 2019 Apr 18.
10
Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.肺泡上皮细胞表面活性蛋白C表达缺失对p53介导的尿激酶型纤溶酶原激活物-纤维蛋白溶解系统变化及肺损伤的调控作用
Am J Physiol Lung Cell Mol Physiol. 2017 Jun 1;312(6):L783-L796. doi: 10.1152/ajplung.00291.2016. Epub 2017 Apr 6.